Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio also includes Dime Bag a pre-roll offering, sold across eight provincial distribution agencies.


TSXV:ENTG - Post by User

Bullboard Posts
Post by kijijion Aug 14, 2019 10:31am
67 Views
Post# 30026867

Completes Phase 1 of Shoppers & TruTrace's verification

Completes Phase 1 of Shoppers & TruTrace's verification
 is pleased to announce that 40 of its medical cannabis strains were included in the completion of the first phase of TruTrace Technologies’ (“TruTrace”, formerly BLOCKStrain Technology Corp.) medical cannabis verification pilot project (the “Pilot Project”) with Shoppers Drug Mart. As recently announced by the parties, together with Deloitte Canada LLP (“Deloitte”), Phase 2 of the Pilot Project is targeted for completion in late November 2019.
 
Built on TruTrace’s proprietary StrainSecure™ system which focuses on cannabis product testing and verification to confirm origin, authenticity and quality, WeedMD is the first and only licensed producer to have 40 strains registered in the program. This technology helps in the protection of WeedMD’s unique strains and assists its customers, including Shoppers Drug Mart, with strain and product authenticity.
 
“WeedMD has long recognized the importance of strain validation,” said Keith Merker, CEO of WeedMD. “As health care practitioners look to prescribe, trust and better understand cannabis science, we’re proud to confirm that 40 WeedMD strains were used in the completion of this pilot project. We congratulate TruTrace, Shoppers Drug Mart and the newly-added Deloitte team on this landmark initiative and we look forward to completing the next phase this fall.”
 
“As the first LP to participate in the strain registry program, WeedMD stands out as a cannabis producer that consistently looks to instill patient and industry trust in the products prescribed and consumed,” said Robert Galarza, CEO of TruTrace Technologies. “The completion of Phase 1 was a collective effort that included the very important participation of WeedMD with their robust library of strains – the only complete set of genetics to be included at this stage – thereby ensuring the integrity of the project’s traceability and origin assurances.”
 
About TruTrace’s StrainSecure Registration Program
 
In January 2019, WeedMD successfully registered forty of its strains using TruTrace's StrainSecure™ technology. Following the collection, sequencing and registration of the DNA of its cannabis strains, WeedMD became the first licensed producer in the world to incorporate a cannabis authenticity and tracking platform into its sales program. 
 
Under the program, TruTrace’s team collects plant data and performs genomic sequencing in plant batches which are then registered in a blockchain-enabled database for intellectual property protection and strain validation. Known as StrainSecure, all information gathered from the plants, including their molecular and chemical makeup, can be tracked via the program.
 
Bullboard Posts